Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Early super-spreader events are a likely determinant of novel SARS-CoV-2 variant predominance

View ORCID ProfileAshish Goyal, View ORCID ProfileDaniel Reeves, View ORCID ProfileJoshua T. Schiffer
doi: https://doi.org/10.1101/2021.03.23.21254185
Ashish Goyal
1Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ashish Goyal
Daniel Reeves
1Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Daniel Reeves
Joshua T. Schiffer
1Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center
2Department of Medicine, University of Washington, Seattle
3Clinical Research Division, Fred Hutchinson Cancer Research Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Joshua T. Schiffer
  • For correspondence: jschiffe@fredhutch.org
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

The emergence of multiple new SARS-CoV-2 variants, characterized to varying degrees by increased infectivity, higher virulence and evasion of vaccine and infection-induced immunologic memory, has hampered international efforts to contain the virus. While it is generally believed that these variants first develop in single individuals with poor immunologic control of the virus, the factors governing variant predominance in the population remain poorly characterized. Here we present a mathematical framework for variant emergence accounting for the highly variable number of people secondarily infected by individuals with SARS-CoV-2 infection. Our simulations suggest that threatening new variants probably develop within infected people fairly commonly, but that most die out and do not achieve permanence in the population. Variants that predominate are more likely to be associated with higher infectiousness, but also the occurrence of a super-spreader event soon after introduction into the population.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

JTS received supplemental COVID funding via National Institute of Allergy and Infectious Diseases (R01 AI121129-05S1) and the Council of State and Territorial Epidemiologists

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

NA

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All code is available upon request.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Back to top
PreviousNext
Posted March 24, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Early super-spreader events are a likely determinant of novel SARS-CoV-2 variant predominance
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Early super-spreader events are a likely determinant of novel SARS-CoV-2 variant predominance
Ashish Goyal, Daniel Reeves, Joshua T. Schiffer
medRxiv 2021.03.23.21254185; doi: https://doi.org/10.1101/2021.03.23.21254185
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Early super-spreader events are a likely determinant of novel SARS-CoV-2 variant predominance
Ashish Goyal, Daniel Reeves, Joshua T. Schiffer
medRxiv 2021.03.23.21254185; doi: https://doi.org/10.1101/2021.03.23.21254185

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (280)
  • Allergy and Immunology (580)
  • Anesthesia (141)
  • Cardiovascular Medicine (1965)
  • Dentistry and Oral Medicine (253)
  • Dermatology (187)
  • Emergency Medicine (336)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (704)
  • Epidemiology (11124)
  • Forensic Medicine (8)
  • Gastroenterology (630)
  • Genetic and Genomic Medicine (3202)
  • Geriatric Medicine (310)
  • Health Economics (567)
  • Health Informatics (2051)
  • Health Policy (864)
  • Health Systems and Quality Improvement (790)
  • Hematology (310)
  • HIV/AIDS (686)
  • Infectious Diseases (except HIV/AIDS) (12745)
  • Intensive Care and Critical Care Medicine (708)
  • Medical Education (319)
  • Medical Ethics (92)
  • Nephrology (339)
  • Neurology (3004)
  • Nursing (167)
  • Nutrition (466)
  • Obstetrics and Gynecology (589)
  • Occupational and Environmental Health (614)
  • Oncology (1563)
  • Ophthalmology (478)
  • Orthopedics (186)
  • Otolaryngology (266)
  • Pain Medicine (203)
  • Palliative Medicine (57)
  • Pathology (403)
  • Pediatrics (915)
  • Pharmacology and Therapeutics (387)
  • Primary Care Research (356)
  • Psychiatry and Clinical Psychology (2807)
  • Public and Global Health (5616)
  • Radiology and Imaging (1102)
  • Rehabilitation Medicine and Physical Therapy (637)
  • Respiratory Medicine (764)
  • Rheumatology (342)
  • Sexual and Reproductive Health (316)
  • Sports Medicine (290)
  • Surgery (348)
  • Toxicology (48)
  • Transplantation (159)
  • Urology (133)